Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1991 Jun;213(6):600–605. doi: 10.1097/00000658-199106000-00010

Nonpalpable invasive breast cancer.

M C Wilhelm 1, S B Edge 1, D D Cole 1, E deParedes 1, H F Frierson Jr 1
PMCID: PMC1358585  PMID: 2039291

Abstract

The use of mammography has resulted in 1464 breast biopsies for nonpalpable abnormalities at the University of Virginia in the 10 years 1980 to 1989. Two hundred sixty-four cancerous lesions (18%) were found. One hundred seventy-eight of these (67%) were in situ lesions. Invasive cancer (86 of 264 lesions or 33%) forms the basis for this report. Mammographic findings leading to biopsy were a mass in 61 of 86 cases (71%), microcalcifications in 23 of 86 (27%), or both in 2 of 86 cases. Histologic subtypes were infiltrating ductal (63 of 86), infiltrating lobular (14 of 86), and other infiltrating (9 of 86). Mastectomy was performed in 71 of 86 lesions (82%), lumpectomy/radiation in 14 of 86 (16%), and lumpectomy alone in 1 of 86 lesions. Division of the tumors into size with nodal status revealed 19 of 86 lesions (22%) less than 0.5 cm with 0 of 14 positive nodes. Thirty-nine of eighty-six lesions (46%) measured 0.6 to 1.0 cm with 10 (26%) positive nodes. Twenty-eight of eighty-six lesions (32%) measured more than 1.0 cm with 8 of 28 (28%) positive nodes. Nodal status is unknown for eight patients. Overall 18 of 78 lesions (23%) had positive nodes. Median follow-up is 44 months. Disease-free survival rate is 92% (79 of 86 patients) and overall survival rate is 94% (81 of 86 patients). Six of seven recurrences occurred in node-positive patients. For those with negative or unknown nodes, the disease-free survival rate is 98% (67 of 68 patients). These findings emphasize the benefit of early detection of breast cancer through the use of mammography.

Full text

PDF
600

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carter C. L., Allen C., Henson D. E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989 Jan 1;63(1):181–187. doi: 10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  2. Ciatto S., Cecchini S., Iossa A., Grazzini G., Bravetti P., Rosselli del Turco M., Cataliotti L., Cardona G., Bianchi S. Prognosis of nonpalpable infiltrating carcinoma of the breast. Surg Gynecol Obstet. 1990 Jan;170(1):61–64. [PubMed] [Google Scholar]
  3. EGAN R. L. Experience with mammography in a tumor institution. Evaluation of 1,000 studies. Radiology. 1960 Dec;75:894–900. doi: 10.1148/75.6.894. [DOI] [PubMed] [Google Scholar]
  4. Henderson I. C., Hayes D. F., Parker L. M., Love S., Garber J. E., Recht A., Breitmeyer J. B., Harris J. R., Canellos G. P. Adjuvant systemic therapy for patients with node-negative tumors. Cancer. 1990 May 1;65(9 Suppl):2132–2147. doi: 10.1002/1097-0142(19900501)65:9+<2132::aid-cncr2820651410>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  5. Henson D. E., Ries L. A. Progress in early breast cancer detection. Cancer. 1990 May 1;65(9 Suppl):2155–2158. doi: 10.1002/1097-0142(19900501)65:9+<2155::aid-cncr2820651412>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  6. Lay S. F., Crump J. M., Frykberg E. R., Goedde T. A., Copeland E. M., 3rd Breast biopsy. Changing patterns during a five-year period. Am Surg. 1990 Feb;56(2):79–85. [PubMed] [Google Scholar]
  7. Papatestas A. E., Hermann D., Hermann G., Tsevdos C., Lesnick G. Surgery for nonpalpable breast lesions. Arch Surg. 1990 Mar;125(3):399–402. doi: 10.1001/archsurg.1990.01410150121023. [DOI] [PubMed] [Google Scholar]
  8. Rosen P. R., Groshen S., Saigo P. E., Kinne D. W., Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol. 1989 Mar;7(3):355–366. doi: 10.1200/JCO.1989.7.3.355. [DOI] [PubMed] [Google Scholar]
  9. Rosner D., Lane W. W. Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapy. Cancer. 1990 Jul 15;66(2):199–205. doi: 10.1002/1097-0142(19900715)66:2<199::aid-cncr2820660202>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  10. Schwartz G. F., Feig S. A., Patchefsky A. S. Significance and staging of nonpalpable carcinomas of the breast. Surg Gynecol Obstet. 1988 Jan;166(1):6–10. [PubMed] [Google Scholar]
  11. Seidman H., Gelb S. K., Silverberg E., LaVerda N., Lubera J. A. Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin. 1987 Sep-Oct;37(5):258–290. doi: 10.3322/canjclin.37.5.258. [DOI] [PubMed] [Google Scholar]
  12. Spivey G. H., Perry B. W., Clark V. A., Coulson A. H., Coulson W. F. Predicting the risk of cancer at the time of breast biopsy. Variation in the benign to malignant ratio. Am Surg. 1982 Jul;48(7):326–332. [PubMed] [Google Scholar]
  13. Symmonds R. E., Jr, Roberts J. W. Management of nonpalpable breast abnormalities. Ann Surg. 1987 May;205(5):520–528. doi: 10.1097/00000658-198705000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Thompson R. S., Taplin S. H., Carter A. P., Schnitzer F. Cost effectiveness in program delivery. Cancer. 1989 Dec 15;64(12 Suppl):2682–2689. doi: 10.1002/1097-0142(19891215)64:2+<2682::aid-cncr2820641412>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  15. Tinnemans J. G., Wobbes T., Holland R., Hendriks J. H., Van der Sluis R. F., De Boer H. H. Treatment and survival of female patients with nonpalpable breast carcinoma. Ann Surg. 1989 Feb;209(2):249–253. doi: 10.1097/00000658-198902000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wilhelm M. C., Wanebo H. J. Technique and guidelines for needle localization biopsy of nonpalpable lesions of the breast. Surg Gynecol Obstet. 1988 Nov;167(5):439–441. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES